Method for improving expression quantity of recombinant protein in bacillus subtilis by means of co-expressing bacillus-derived enhancement factor
By co-expressing the enhancement factors PonA, OppA or SppA from Bacillus subtilis in Bacillus subtilis, the problem of limited expression of recombinant proteins is solved, significantly improving the expression efficiency of proteins and improving the production capacity of Bacillus subtilis as an expression host.
Patent Information
- Application Number
- PCT/CN2023/135786
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-23
- Filing Date
- 2023-12-01
- Publication Date
- 2024-11-28
AI Technical Summary
In the prior art, Bacillus subtilis, as a recombinant protein expression host, has limited expression amount, and the existing modification strategies are relatively one-sided, and have failed to fully regulate the protein synthesis and secretion process, limiting its further development as an expression host.
The expression of recombinant proteins in Bacillus subtilis is increased by overexpressing the Bacillus-derived A-class penicillin-binding protein PonA, the ABC pathway transporter OppA or the signal peptide peptidase SppA, and these enhancers are expressed to enhance protein production capacity. .
The expression of recombinant proteins was significantly increased, the enzyme activity of ultra-high temperature amylase was increased to 2.03 times, the expression of medium temperature amylase and sucrose isomerase was increased to 1.42 times and 1.92 times, and the expression of PonA or its truncated body and recombinant proteins were co-expressed. The expression volume increased to 1.71-3.96 times, improving the production efficiency of protein.
Smart Images

Figure CN2023135786_28112024_PF_FP_ABST
Abstract
Description
A method for increasing the expression of recombinant proteins in Bacillus subtilis by co-expressing Bacillus-derived enhancer factors Technical Field
[0001] The invention relates to a method for co-expressing a Bacillus-derived enhancer factor to increase the expression amount of a recombinant protein in Bacillus subtilis, and belongs to the technical field of enzyme engineering. Background Art
[0002] Bacillus subtilis is a Gram-positive strain of the genus Bacillus (Bacillus Cohn). Because B. subtilis does not produce toxins or heat-sensitizing proteins, it is listed as a certified strain on the US FDA's "GRAS (Generally Recognized as Safe)" list. Its ease of isolation and culture, high-density fermentation, and strong protein secretion make it an important industrial strain for the production of a variety of exogenous recombinant proteins and metabolites. Its excellent traits have a high identification value. Furthermore, B. subtilis has a clear genetic background and mature molecular biology gene editing methods, which facilitates genetic modification to enhance its expression capacity as a recombinant protein production host.
[0003] Further improving the ability of Bacillus subtilis to produce exogenous proteins is a top research priority. Numerous strategies have been employed to engineer this model organism to achieve higher recombinant protein yields, such as overexpressing Sec pathway-related factors, knocking out intracellular or extracellular proteases, and increasing chaperone protein content. However, the selection of these engineering targets relies heavily on the existing annotation of functional genes in Bacillus subtilis, as protein synthesis and secretion are not regulated by a single pathway. Studies have shown that genes regulating physiological functions play important roles in protein expression or metabolite accumulation. For example, Jennifer Staudacher increased heterologous protein expression by threefold by upregulating the expression of translation initiation factors, and Xiao-Ran Jiang increased PHB production by 1.8-fold by manipulating cell morphology control genes. Therefore, the current annotation of pathways involved in protein synthesis and secretion is incomplete, which means that current engineering strategies are relatively one-sided, thus limiting the further development of Bacillus subtilis as an expression host.
[0004] At present, the identification of factors that play a key role in the protein expression process is still incomplete, so there is an urgent need to develop other new factors that can enhance the expression of recombinant proteins in Bacillus subtilis based on the existing ones.
[0005] Summary of the Invention
[0006] In order to solve the problem of limited expression of recombinant proteins in Bacillus subtilis in the prior art, the present invention provides a method for increasing the expression of recombinant proteins in Bacillus subtilis. The method overexpresses Bacillus class A penicillin-binding protein PonA, a truncated form of class A penicillin-binding protein PonA, an ABC pathway transporter OppA, or a signal peptide peptidase SppA while expressing the recombinant protein.
[0007] In one embodiment, the PonA is a class A penicillin-binding protein derived from Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus megaterium or Geobacillus stearothermophilus.
[0008] In one embodiment, the PonA protein derived from Bacillus subtilis is PonA(Bs), having the amino acid sequence shown in SEQ ID NO.1, or an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.1.
[0009] In one embodiment, the PonA protein derived from Bacillus licheniformis is PonA (Bl), having the amino acid sequence shown in SEQ ID NO.2, or an amino acid sequence having 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identity with SEQ ID NO.2.
[0010] In one embodiment, the PonA protein derived from Bacillus amyloliquefaciens is PonA(Ba), having the amino acid sequence shown in SEQ ID NO.3, or an amino acid sequence having 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identity with SEQ ID NO.3.
[0011] In one embodiment, the PonA protein derived from Bacillus megaterium is PonA (Bm), having the amino acid sequence shown in SEQ ID NO. 4, or having an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO. 4.
[0012] In one embodiment, the PonA protein derived from Geobacillus stearothermophilus is PonA(Gs), having the amino acid sequence shown in SEQ ID NO.5, or having an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.5.
[0013] In one embodiment, the PonA truncation is a truncation of a class A penicillin-binding protein derived from Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus megaterium, or Geobacillus stearothermophilus.
[0014] In one embodiment, the truncated PonA protein from Bacillus subtilis is DcPonA (Bs), having the amino acid sequence shown in SEQ ID NO. 6, or having an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO. 6.
[0015] In one embodiment, the truncated PonA protein from Bacillus licheniformis is DcPonA (Bl), having the amino acid sequence shown in SEQ ID NO.7, or an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.7.
[0016] In one embodiment, the truncated PonA protein derived from Bacillus amyloliquefaciens is DcPonA(Ba), having the amino acid sequence shown in SEQ ID NO.8, or having an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.8.
[0017] In one embodiment, the truncated PonA protein from Bacillus megaterium is DcPonA (Bm), having the amino acid sequence shown in SEQ ID NO.9, or having an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.9.
[0018] In one embodiment, the truncated PonA protein from Geobacillus stearothermophilus is DcPonA(Gs), having the amino acid sequence shown in SEQ ID NO.10, or an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.10.
[0019] In one embodiment, the ABC pathway transporter OppA derived from Bacillus subtilis has the amino acid sequence shown in SEQ ID NO.21; the signal peptide peptidase SppA derived from Bacillus subtilis has the amino acid sequence shown in SEQ ID NO.22.
[0020] In one embodiment, the recombinant protein includes but is not limited to ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
[0021] In one embodiment, the ultrahigh temperature amylase has the amino acid sequence shown in SEQ ID NO.23, or an amino acid sequence having 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identity with SEQ ID NO.23.
[0022] In one embodiment, the mesophilic amylase has the amino acid sequence shown in SEQ ID NO. 24, or an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO. 24.
[0023] In one embodiment, the sucrose isomerase has the amino acid sequence shown in SEQ ID NO.25, or an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to SEQ ID NO.25.
[0024] In one embodiment, pUB110 is used as an expression vector to express ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
[0025] In one embodiment, pAD123 is used as an expression vector to express the class A penicillin-binding protein PonA, the class A penicillin-binding protein PonA truncated form, the ABC pathway transporter OppA or the signal peptide peptidase SppA.
[0026] In one embodiment, the method is to express the recombinant protein and the PonA, OppA and SppA in the same host.
[0027] In one embodiment, the host includes but is not limited to Bacillus subtilis SCK6.
[0028] In one embodiment, the recombinant protein is expressed via a constitutive promoter P amyQ’ To express, the promoter P amyQ’ The nucleotide sequence is shown in SEQ ID NO.31.
[0029] In one embodiment, the class A penicillin binding protein PonA, the class A penicillin binding protein PonA truncated form, the ABC pathway transporter OppA or the signal peptide peptidase SppA is expressed through the promoter P glv or promoter P HpaII To express.
[0030] In one embodiment, the promoter P HpaII The nucleotide sequence is shown in SEQ ID NO.32.
[0031] In one embodiment, the promoter P glv The nucleotide sequence is shown in SEQ ID NO.33.
[0032] The present invention also provides a recombinant Bacillus subtilis bacterium with increased expression of exogenous proteins. The recombinant Bacillus subtilis bacterium co-expresses the class A penicillin-binding protein PonA or DcPonA derived from Bacillus subtilis, the ABC pathway transporter OppA derived from Bacillus subtilis, or the signal peptide peptidase SppA derived from Bacillus subtilis while expressing the exogenous protein.
[0033] In one embodiment, the exogenous protein refers to a protein that is exogenous to the Bacillus subtilis that expresses and secretes the protein. For example, the exogenous protein can be a protein derived from a microorganism, a plant, an animal, a virus, or even a protein whose amino acid sequence is artificially designed. In particular, the heterologous protein can be a protein derived from humans. The heterologous protein can be a monomeric protein or a multimeric protein. "Multimeric protein" refers to a protein that can exist as a multimer comprising two or more subunits. In a multimer, the subunits can be connected by covalent bonds such as disulfide bonds; can be connected by non-covalent bonds such as hydrogen bonds and hydrophobic interactions, or can be connected by a combination thereof. Preferably, one or more intermolecular disulfide bonds are contained in the multimer. The multimer can be a homomultimer comprising a single type of subunits, or a heteromultimer comprising two or more types of subunits. It should be noted that when the multimeric protein is a heteromultimer, at least one of the subunits comprising the multimer may be a heterologous protein. That is, all subunits may be heterologous, or only a portion of the subunits may be heterologous. The heterologous protein may be a naturally secreted protein or a naturally non-secreted protein, preferably a naturally secreted protein. Furthermore, the heterologous protein may be a naturally secreted Tat-dependent protein or a naturally secreted Sec-dependent protein.
[0034] In one embodiment, pUB110 is used as an expression vector to express ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
[0035] In one embodiment, pAD123 is used as an expression vector to express the class A penicillin-binding protein PonA, the class A penicillin-binding protein PonA truncated form, the ABC pathway transporter OppA or the signal peptide peptidase SppA.
[0036] The present invention also provides a method for constructing the recombinant Bacillus subtilis, which comprises introducing a gene encoding a recombinant protein and a gene encoding an enhancement factor into the Bacillus subtilis.
[0037] In one embodiment, the gene encoding the enhancer factor includes but is not limited to a gene encoding the class A penicillin-binding protein PonA, a truncated form of the class A penicillin-binding protein PonA, an ABC pathway transporter OppA, or a signal peptide peptidase SppA.
[0038] In one embodiment, the gene encoding the class A penicillin-binding protein PonA has a nucleotide sequence shown in any one of SEQ ID NO.11 to SEQ ID NO.15.
[0039] In one embodiment, the gene encoding the truncated form of the class A penicillin-binding protein PonA has a nucleotide sequence shown in any one of SEQ ID NO. 16 to SEQ ID NO. 20.
[0040] In one embodiment, the gene encoding the recombinant protein includes but is not limited to a gene encoding ultrahigh temperature amylase, mesophilic amylase or sucrose isomerase.
[0041] In one embodiment, the gene encoding the ultrahigh temperature amylase has a nucleotide sequence shown in SEQ ID NO.28.
[0042] In one embodiment, the gene encoding the mesophilic amylase has a nucleotide sequence shown in SEQ ID NO.29.
[0043] In one embodiment, the gene encoding the sucrose isomerase has a nucleotide sequence shown in SEQ ID NO.30.
[0044] The present invention also provides the use of the recombinant Bacillus subtilis in producing ultrahigh-temperature amylase, mesophilic amylase or sucrose isomerase.
[0045] In one embodiment, the application is to culture the recombinant bacteria in a fermentation medium for a period of time and collect the ultrahigh temperature amylase, mesophilic amylase or sucrose isomerase.
[0046] In one embodiment, the application is fermentation at 30-40°C, or 30-37°C, or 35-40°C, or 37-40°C, or 35-37°C.
[0047] In one embodiment, the fermentation is fermented for at least 24 hours, or at least 36 hours, or at least 42 hours, or at least 48 hours, or at least 60 hours.
[0048] In one embodiment, the fermentation medium comprises yeast powder, soy peptone, ammonium citrate and metal ions.
[0049] In one embodiment, the fermentation medium contains 9.0 g / L yeast powder, 18 g / L soy peptone, 1.0 g / L ammonium citrate, 14.66 g / L K2HPO4·3H2O, 2.68 g / L (NH4)2SO4, 2.0 g / L Na2SO3, 3.49 g / L NaH2PO4, 0.49 g / L MgSO4, and 0.3% v / v TES metal ion solution.
[0050] In one embodiment, the TES metal ion solution contains: CaCl2 0.5 g / L, ZnSO4·7H2O 0.18 g / L, MnSO4·H2O 0.1 g / L, FeCl3 8.35 g / L, CuSO4·5H2O 0.16 g / L, CoCl2·6H2O 0.18 g / L, and Na2·EDTA 10.5 g / L.
[0051] In one embodiment, feeding is also performed during the fermentation process.
[0052] In one embodiment, the feed is the addition of a feed medium containing glucose.
[0053] In one embodiment, the feed medium contains glucose, soy peptone, yeast powder and metal ions.
[0054] In one embodiment, the feed medium contains 250.0 g / L glucose, 66.66 g / L soy peptone, 33.33 g / L yeast powder, 0.39 g / L MgSO4, and 4.0% v / v TES metal ion solution.
[0055] The present invention also provides the application of the recombinant Bacillus subtilis bacteria or the method in producing products in the fields of food, chemical industry, sugar production, feed, etc. Beneficial effects:
[0056] (1) The present invention significantly increases the expression level of the recombinant protein in Bacillus subtilis by overexpressing the enhancing factors PonA, OppA or SppA derived from Bacillus, and can increase the activity of ultrahigh temperature amylase to 2.03 times, 1.42 times and 1.92 times that of the wild type.
[0057] (2) The present invention also screened the enhancing factor PonA protein from different sources, which can increase the expression level of co-expressed ultrahigh temperature amylase to 1.71 to 3.96 times compared with the control strain.
[0058] (3) The present invention truncated the FN3 domain of PonA protein from different sources, and the obtained truncated DcPonA was co-expressed with ultrahigh temperature amylase, which increased the expression level of ultrahigh temperature amylase by 2.02 to 3.35 times compared with the control strain. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] FIG1 is a schematic diagram showing the effect of recombinant bacteria co-expressing PonA, OppA or SppA from Bacillus subtilis on the enzymatic activities of ultra-high-temperature amylase, mesophilic amylase and sucrose isomerase.
[0060] FIG2 is a schematic diagram of the shake flask bacterial cell concentration and enzyme activity of the recombinant strain co-expressing Bacillus-derived PonA or its genetically engineered truncation DcPonA and ultrahigh-temperature amylase.
[0061] Figure 3 is a graph showing the bacterial concentration and enzyme activity of recombinant strains co-expressing PonA(Bs) and ultrahigh-temperature amylase in a 3L bioreactor; (a) SCK6 / pfa-ck, (b) SCK6 / pfa-ponA(Bs).
[0062] FIG4 is an electrophoretic diagram of SDS-PAGE analysis of fermentation samples of the recombinant strain co-expressing PonA(Bs) and ultrahigh temperature amylase in a 3 L bioreactor.
[0063] FIG5 is a schematic diagram of the shake flask cell concentration and enzyme activity of the recombinant strain co-expressing PonA or its similar protein teichoic acid synthase LtaS from Bacillus subtilis and ultrahigh temperature amylase. DETAILED DESCRIPTION
[0064] (1) The abbreviation and full name of the invention, as well as the Chinese and English translations:
[0065] PonA: class A penicillin-binding protein;
[0066] OppA: ABC pathway transporter;
[0067] SppA: signal peptide peptidase;
[0068] ponA(Bs): Class A penicillin-binding protein from Bacillus subtilis 168;
[0069] ponA(Bl): Class A penicillin-binding protein from Bacillus licheniformis DSM13;
[0070] ponA(Ba): Class A penicillin-binding protein from Bacillus amyloliquefaciens DSM7;
[0071] ponA(Bm): Class A penicillin-binding protein from Bacillus megaterium DSM319;
[0072] ponA(Gs): Class A penicillin-binding protein from Geobacillus stearothermophilus ATCC 7953;
[0073] DcPonA(Bs): truncated class A penicillin-binding protein from Bacillus subtilis 168;
[0074] DcPonA(Bl): truncated class A penicillin-binding protein from Bacillus licheniformis DSM13;
[0075] DcPonA(Ba): truncated class A penicillin-binding protein from Bacillus amyloliquefaciens DSM7;
[0076] DcPonA(Bm): truncated class A penicillin-binding protein from Bacillus megaterium DSM319;
[0077] DcPonA(Gs): truncated class A penicillin-binding protein from Geobacillus stearothermophilus ATCC 7953;
[0078] LB: Luria-Bertani medium, used for the culture of Bacillus subtilis.
[0079] TB: Terrific Broth, super broth medium.
[0080] (2) Detection methods involved in specific embodiments of the present invention:
[0081] (1) Biomass determination:
[0082] The bacterial concentration (OD 600 After sampling, the sample was diluted with deionized water to an appropriate multiple and placed in a spectrophotometer to measure the absorbance at 600 nm.
[0083] (2) Determination of ultra-high temperature amylase activity:
[0084] For detailed procedures, please refer to the literature (Tan Ruiting, Zhang Kang, Wu Jing. Secretory expression of hyperthermogenic α-amylase from thermophilic archaea in Bacillus subtilis [J]. Genomics and Applied Biology). The enzyme activity determination formula is: U (U·mL -1 )=n×(6.0539×△540+0.3494), where U is the enzyme activity unit, n is the enzyme solution dilution multiple, △540 is the sample at OD 540 The absorbance value of the blank group was subtracted from the absorbance value measured.
[0085] (3) Determination of amylase activity at medium temperature:
[0086] For specific operations, please refer to the literature (Yao D, Zhang K, Zhu X, et al. Enhanced extracellular α-amylase production in Brevibacillus choshinensis by optimizing extracellular degradation and folding environment [J]. Journal of Industrial Microbiology and Biotechnology, 2021 (1): 1.). The enzyme activity determination formula is: U (U mL -1 )=n×(6.0539×△540+0.3494), where U is the enzyme activity unit, n is the enzyme solution dilution multiple, △540 is the sample at OD 540 The absorbance value of the blank group was subtracted from the absorbance value measured.
[0087] (4) Determination of sucrose isomerase activity:
[0088] For detailed operations, please refer to the literature (Liu Juntong, Wu Jing, Chen Sheng. Expression and fermentation optimization of Pantoea dispersa sucrose isomerase in Escherichia coli [J]. Chinese Journal of Biotechnology, 2016, 032(008): 1070-1080). The enzyme activity determination formula is: U (U·mL -1 )=n×(6.0539×△540+0.3494), where U is the enzyme activity unit, n is the enzyme solution dilution multiple, △540 is the sample at OD 540 The absorbance value of the blank group was subtracted from the absorbance value measured.
[0089] (III) Culture medium involved in the specific embodiments of the present invention:
[0090] All culture media were prepared using ddH2O and sterilized at 121°C for 20 min.
[0091] LB liquid medium: yeast powder 5.0 g / L, tryptone 10.0 g / L, NaCl 10.0 g / L.
[0092] TB liquid medium: yeast powder 24.0 g / L, tryptone 12.0 g / L, glycerol 5.0 g / L, K2HPO4·3H2O 16.43 g / L, KH2PO4 2.31 g / L.
[0093] 3L fermentor basal medium: yeast powder 9.0g / L, soy peptone 18g / L, ammonium citrate 1.0g / L, K2HPO4·3H2O 14.66g / L, (NH4)2SO4 2.68g / L, Na2SO3 2.0g / L, NaH2PO4 3.49g / L, MgSO4 0.49g / L, TES metal ion solution 0.3% v / v.
[0094] 3L fermenter feed medium: glucose 250.0 g / L, soy peptone 66.66 g / L, yeast powder 33.33 g / L, MgSO4 0.39 g / L, TES metal ion solution 4.0% v / v.
[0095] TES metal ion solution: CaCl2 0.5g / L, ZnSO4·7H2O 0.18g / L, MnSO4·H2O 0.1g / L, FeCl3 8.35g / L, CuSO4·5H2O 0.16g / L, CoCl2·6H2O 0.18g / L, Na2·EDTA 10.5g / L.
[0096] Example 1 Construction of recombinant bacteria expressing ultrahigh temperature amylase, mesophilic amylase or sucrose isomerase
[0097] The gene fragments pfa, amyS, and si, whose nucleotide sequences are shown in SEQ ID NO. 28, SEQ ID NO. 29, and SEQ ID NO. 30, were amplified by PCR from the ultra-high temperature amylase, mesophilic amylase, and sucrose isomerase expression strains, respectively. After gel recovery, they were ligated into the pUB110 vector by PCR. The recombinant proteins were expressed by the constitutive promoter P shown in SEQ ID NO. 31. amyQ’The poe-PCR product was then transformed into Bacillus subtilis SCK6, incubated on ice for 20 minutes, in a 37°C water bath for 20 minutes, and revived at 37°C, 200 rpm, for 3 hours. The cells were then plated on LB plates containing kanamycin resistance (40 μg / mL). Recombinant strains were obtained by screening and verification after overnight culture. The recombinant strains were named BSP, BSA, and BSS, respectively. Among them, the recombinant bacteria used to obtain the pfa, amyS and si genes were constructed in the early stage by the inventor team (published in: Tan Ruiting, Zhang Kang, Wu Jing. Secretory expression of hyperthermophilic archaea α-amylase in B. subtilis [J]. Genomics and Applied Biology; Yao D, Zhang K, Zhu X, et al. Enhanced extracellular α-amylase production in Brevibacillus choshinensis by optimizing extracellular degradation and folding environment [J]. Journal of Industrial Microbiology and Biotechnology, 2021 (1): 1.; Liu Juntong, Wu Jing, Chen Sheng. Expression and fermentation optimization of dispersed Pantoea sucrose isomerase in Escherichia coli [J]. Chinese Journal of Biotechnology, 2016, 032 (008): 1070-1080).
[0098] Example 2 Construction of Enhancer Factor Co-expression Plasmid
[0099] (1) Construction of recombinant plasmid pAD123-PonA
[0100] The ponA gene fragment shown in SEQ ID NO.11 was amplified from the Bacillus subtilis genome using PCR. After gel recovery, it was ligated into the pAD123 vector using the ClonExpress II One Step Cloning Kit. The maltose-inducible promoter P shown in SEQ ID NO.33 was used to express the ponA gene fragment. glv The expression was regulated and subsequently transformed into Escherichia coli JM109, incubated on ice for 30 minutes, in a 42°C water bath for 90 seconds, in an ice bath for 3 minutes, and revived at 37°C at 200 rpm for 1 hour. The cells were then plated on LB plates containing ampicillin (100 μg / mL) and cultured overnight. Recombinant plasmids were obtained after screening and verification.
[0101] (2) Construction of recombinant plasmid pAD123-OppA
[0102] The oppA gene fragment with the nucleotide sequence shown in SEQ ID NO.26 was amplified from the Bacillus subtilis genome by PCR. The sequence was recovered from gel and ligated into the pAD123 vector using the ClonExpress II One Step Cloning Kit. The oppA gene fragment was expressed by the maltose-inducible promoter shown in SEQ ID NO.33. glv The expression was regulated and subsequently transformed into Escherichia coli JM109, incubated on ice for 30 minutes, in a 42°C water bath for 90 seconds, in an ice bath for 3 minutes, and revived at 37°C at 200 rpm for 1 hour. The cells were then plated on LB plates containing ampicillin (100 μg / mL) and cultured overnight. Recombinant plasmids were obtained after screening and verification.
[0103] (3) Construction of recombinant plasmid pAD123-SppA
[0104] The sppA gene fragment was amplified from the genome of B. subtilis 168 by PCR. Its sequence is shown in SEQ ID NO. 22. After gel extraction, it was ligated into the pAD123 vector using the ClonExpress II One Step Cloning Kit. The sppA gene fragment was expressed by the maltose-inducible promoter P shown in SEQ ID NO. 33. glv The expression was regulated and subsequently transformed into Escherichia coli JM109, incubated on ice for 30 minutes, in a 42°C water bath for 90 seconds, in an ice bath for 3 minutes, and revived at 37°C at 200 rpm for 1 hour. The cells were then plated on LB plates containing ampicillin (100 μg / mL) and cultured overnight. Recombinant plasmids were obtained after screening and verification.
[0105] Example 3 Construction of co-expressing recombinant bacteria producing ultra-high temperature amylase, mesophilic amylase or sucrose isomerase
[0106] The correct recombinant plasmids pAD123-PonA, pAD123-OppA and pAD123-SppA constructed in Example 2 were transformed into competent cells of recombinant bacteria BSP, BSA and BSS constructed in Example 1 respectively. Ice bath for 20 min, 37 ° C water bath for 20 min, 37 ° C, 200 rpm recovery for 3 h, coated on LB plates containing kanamycin resistance (40 μg / mL) and chloramphenicol resistance (10 μg / mL), cultured overnight, and recombinant bacteria expressing recombinant protein and enhancing factor were obtained. The correct recombinant bacteria were inoculated in 10 mL of LB culture medium containing kanamycin resistance (40 μg / mL) and chloramphenicol resistance (10 μg / mL) with an inoculum size of 2 ‰, and cultured at 37 ° C, 200 rpm for 10 h as fermentation seed liquid. Subsequently, a 5% inoculum was transferred to 50 mL of TB medium containing the same antibiotic concentration. Expression was induced by the addition of 5 g / L maltose. Culture was initially performed at 37°C for 2 hours, after which the temperature was adjusted to 33°C until the end of the fermentation. The strain expressing ultra-high-temperature amylase was cultured for 60 hours, while the strain expressing mesophilic amylase and sucrose isomerase was cultured for 48 hours. The fermentation supernatant was then diluted appropriately and assayed for enzyme activity.
[0107] The activities of the three recombinant proteases in the fermentation supernatant are shown in Figure 1. When the model enzyme was ultra-high-temperature amylase, co-expression of PonA, OppA, and SppA increased the enzyme activities to 2.03-fold, 1.42-fold, and 1.92-fold of the wild-type, respectively, with no significant difference in bacterial OD. When the model enzyme was mesophilic amylase, co-expression of PonA and OppA increased the enzyme activities to 1.49-fold and 1.38-fold of the wild-type, respectively, and there was no significant difference in bacterial OD during fermentation between the PonA and OppA overexpressing strains. When the model enzyme was sucrose isomerase, co-expression of PonA and SppA increased the enzyme activities to 1.52-fold and 2.26-fold of the wild-type, respectively. Overexpression of PonA significantly decreased bacterial OD, while overexpression of SppA significantly increased bacterial concentration.
[0108] Example 4 Construction of recombinant plasmids expressing PonA from different sources
[0109] The ponA(Bs), ponA(Bl), ponA(Ba), ponA(Bm), and ponA(Gs) gene fragments were amplified from the genomes of B. subtilis 168, Bacillus licheniformis DSM13, Bacillus amyloliquefaciens DSM7, Bacillus megaterium DSM319, and Geobacillus stearothermophilus ATCC7953 by PCR. Their nucleotide sequences are shown as SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13, SEQ ID NO.14, and SEQ ID NO.15, respectively. After gel recovery, they were ligated into the pAD123 vector using the ClonExpress II One Step Cloning Kit and expressed under the control of the maltose-inducible promoter P glv The expression was regulated and subsequently transformed into Escherichia coli JM109, incubated on ice for 30 minutes, in a 42°C water bath for 90 seconds, in an ice bath for 3 minutes, and revived at 37°C at 200 rpm for 1 hour. The cells were then plated on LB plates containing ampicillin (100 μg / mL) and cultured overnight. Recombinant plasmids were obtained after screening and verification.
[0110] Example 5 Construction of a recombinant plasmid expressing the FN3 domain truncated DcPonA
[0111] The C-terminal FN3 domain of PonA was truncated by homologous recombination using PCR to obtain DcPonA(Bs), DcPonA(Bl), DcPonA(Ba), DcPonA(Bm), and DcPonA(Gs) fragments as shown in SEQ ID NOs. 16, 17, 18, 19, and 20, respectively. Following the same strategy as in Example 4, the PCR products were gel-recovered and ligated into the pAD123 vector using a ClonExpress II One-Step Cloning Kit. The template was then digested with dpnI and transformed into Escherichia coli JM109. The cells were incubated on ice for 30 minutes, in a 42°C water bath for 90 seconds, in an ice bath for 3 minutes, and then revived at 37°C at 200 rpm for 1 hour. The cells were then plated on LB plates containing ampicillin (100 μg / mL) and cultured overnight. Recombinant plasmids were obtained after screening and verification.
[0112] Example 6: Synthesis of ultrahigh temperature amylase by shake flask fermentation of PonA or DcPonA co-expressing recombinant bacteria
[0113] The recombinant plasmids constructed correctly in Example 4 and Example 5 were respectively transformed into the recombinant bacteria BSP constructed in Example 1, ice bathed for 20 min, water bathed at 37°C for 20 min, revived at 37°C, 200 rpm for 3 h, and coated on LB plates containing kanamycin resistance (40 μg / mL) and chloramphenicol resistance (10 μg / mL). Cultured overnight to obtain recombinant bacteria expressing ultrahigh temperature amylase Pfa and PonA proteins, or recombinant bacteria expressing ultrahigh temperature amylase Pfa and DcPonA proteins. The recombinant bacteria that were verified to be correct were inoculated with an inoculum size of 2‰ in 10 mL of LB medium containing kanamycin resistance (40 μg / mL) and chloramphenicol resistance (10 μg / mL), and cultured at 37°C, 200 rpm for 10 h as a fermentation seed liquid. A 5% inoculum was then transferred to 50 mL of TB medium containing the same antibiotic concentration. Expression was induced by the addition of 5 g / L maltose. Culture was initially maintained at 37°C for 2 hours, after which the temperature was adjusted to 33°C for 60 hours. The fermentation supernatant was then diluted appropriately and assayed for Pfa expression using the enzyme activity assay described above. A recombinant strain, obtained by transforming only the pAD123 plasmid into the recombinant BSP strain without expressing PonA or DcPonA, served as a control.
[0114] Figure 2 shows the Pfa enzyme activity in the fermentation supernatant. With the exception of PonA(Bl), recombinant strains expressing other Bacillus-derived PonA proteins showed significant increases in protein expression compared to the control strain. After 60 hours of fermentation, the enzyme activities of recombinant strains co-expressing PonA(Bs), PonA(Ba), PonA(Bm), and PonA(Gs) were measured to be 74.17 U / mL, 82.07 U / mL, 143.98 U / mL, and 171.76 U / mL, respectively. These increases were 1.71-fold, 1.89-fold, 3.32-fold, and 3.96-fold, respectively, compared to the control strain. Recombinant strains co-expressing DcPonA also showed significant increases in Pfa enzyme activity compared to the control strain. After 60 hours of fermentation, the enzyme activities of the recombinant strains co-expressing DcPonA(Bs), DcPonA(Bl), DcPonA(Ba), DcPonA(Bm), and DcPonA(Gs) were measured to be 90.48 U / mL, 143.48 U / mL, 94.04 U / mL, 87.68 U / mL, and 145.26 U / mL, respectively. These activities were increased by 2.09-fold, 3.31-fold, 2.17-fold, 2.02-fold, and 3.35-fold compared to the control strain, respectively.
[0115] Example 7 Promoter Optimization
[0116] Construction of plasmid pAD123-P constitutively expressing PonA HpaII-PonA(Bs), specifically: using PCR method to amplify the promoter P of nucleotide sequence shown in SEQ ID NO.32 from the genome of B.subtilis 168 HpaII After gel recovery, the gene fragment was ligated to the vector pAD123-PonA(Bs) carrying PonA(Bs) constructed in Example 4 using the ClonExpress II One Step Cloning Kit. The fragment was then transformed into Escherichia coli JM109, ice-bathed for 30 minutes, in a 42°C water bath for 90 seconds, ice-bathed for 3 minutes, and revived at 37°C at 200 rpm for 1 hour. The fragment was then plated on an LB plate containing ampicillin resistance (100 μg / mL) and cultured overnight. The recombinant plasmid pAD123-P was obtained after screening and verification. HpaII -PonA(Bs).
[0117] Example 8 Synthesis of ultrahigh temperature amylase by horizontal fermentation in a 3L fermenter
[0118] The correct recombinant plasmid pAD123-P constructed in Example 7 was HpaII -PonA(Bs) was transformed into the recombinant BSP competent cells constructed in Example 1, incubated on ice for 20 min, in a 37°C water bath for 20 min, and revived at 37°C, 200 rpm for 3 h. The cells were spread on LB plates containing kanamycin resistance (40 μg / mL) and chloramphenicol resistance (10 μg / mL), and cultured overnight to obtain recombinant bacteria with constitutive PonA overexpression. The strain freshly stored in a glycerol tube was cultured at 37°C for 10 hours using the plate streak method. A single colony was picked and transferred to 50 mL of LB medium containing kanamycin (40 μg / mL) and chloramphenicol (10 μg / mL). The culture was incubated at 37°C and 200 rpm for 12 hours. Then, a 10% transfer volume was transferred to 900 mL of fermentation medium containing kanamycin (40 μg / mL) and chloramphenicol (10 μg / mL). The temperature was adjusted to 33°C, and the pH was controlled at 7.0 with ammonia and 20% phosphoric acid. Feeding was started when dissolved oxygen rebound occurred after 6.5 to 8 hours of fermentation. The feed flow rate was controlled to ensure that the residual sugar content in the system was no higher than 0.1 g / L. Samples were taken regularly to determine the bacterial concentration and ultrahigh temperature amylase activity in the fermentation broth. The total enzyme activity of the control strain reached 1611.86 U / mL at 90 hours of fermentation (Figure 3a), while that of the PonA(Bs) co-expressing strain reached 2041.73 U / mL at 102 hours (Figure 3b), representing a 1.26-fold increase in enzyme activity compared to the control strain. The bacterial concentrations of the two recombinant strains remained essentially the same throughout the high-density fermentation cycle, and SDS-PAGE analysis revealed protein bands that aligned with the enzyme activity trends (Figure 4).
[0119] Comparative Example 1:
[0120] The specific implementation method is the same as that of Examples 5 to 6, except that the regulatory factor is replaced, specifically: PonA is replaced with the main teichoic acid synthase LtaS in Bacillus subtilis (amino acid sequence as shown in SEQ ID NO.34, gene sequence as shown in SEQ ID NO.35). The results showed that LtaS overexpression only increased the enzyme activity of Pfa to 1.52 times, which is significantly lower than the effect of PonA on Pfa expression (2.03 times). Under the same fermentation conditions, OD 600 There were no significant changes (Figure 5).
[0121] Although the present invention has been disclosed above in terms of preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A recombinant Bacillus subtilis, characterized in that: Expression of foreign protein and any one of (1) to (4): (1) Class A penicillin-binding protein PonA from Bacillus; (2) DcPonA, a truncated version of the class A penicillin-binding protein from Bacillus; (3) ABC pathway transporter OppA from Bacillus subtilis; (4) Signal peptide peptidase SppA from Bacillus subtilis; The PonA is a class A penicillin binding protein derived from Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus megaterium or Geobacillus stearothermophilus; The PonA truncate is a truncate of a class A penicillin binding protein derived from Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus megaterium or Geobacillus stearothermophilus.
2. The recombinant Bacillus subtilis according to claim 1, characterized in that The PonA protein has an amino acid sequence shown in any one of SEQ ID NOs. 1 to 5, or an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to the sequence shown in SEQ ID NOs. 1 to 5.
3. The recombinant Bacillus subtilis according to claim 1, characterized in that The PonA protein truncate has an amino acid sequence shown in any one of SEQ ID NOs. 6 to 10, or has an amino acid sequence that is 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.9% identical to the sequence shown in SEQ ID NOs. 6 to 10.
4. The recombinant Bacillus subtilis according to any one of claims 1 to 3, characterized in that: The exogenous protein includes ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
5. The recombinant Bacillus subtilis according to claim 4, characterized in that pUB110 was used as an expression vector to express ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
6. The recombinant Bacillus subtilis according to any one of claims 1 to 5, characterized in that pAD123 is used as an expression vector to express the class A penicillin binding protein PonA, the class A penicillin binding protein PonA truncated body, the ABC pathway transport protein OppA or the signal peptide peptidase SppA.
7. The recombinant Bacillus subtilis according to any one of claims 1 to 6, characterized in that: The exogenous protein is expressed via a constitutive promoter P amyQ’ To express.
8. The recombinant Bacillus subtilis according to any one of claims 1 to 7, characterized in that: The class A penicillin binding protein PonA, the class A penicillin binding protein PonA truncated body, the ABC pathway transport protein OppA or the signal peptide peptidase SppA is expressed by the promoter P glv or promoter P HpaII To express.
9. The recombinant Bacillus subtilis according to any one of claims 1 to 8, characterized in that Hosts include Bacillus subtilis SCK6.
10. A method for increasing the expression of a recombinant protein in Bacillus subtilis, characterized in that: The method is to over-express Bacillus class A penicillin binding protein PonA, class A penicillin binding protein PonA truncated body, ABC pathway transport protein OppA or signal peptide peptidase SppA while expressing the recombinant protein.
11. The method according to claim 10, characterized in that The recombinant protein includes ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
12. The method according to claim 11, characterized in that pUB110 was used as an expression vector to express ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
13. The method according to any one of claims 10 to 12, characterized in that: pAD123 is used as an expression vector to express the class A penicillin binding protein PonA, the class A penicillin binding protein PonA truncated body, the ABC pathway transport protein OppA or the signal peptide peptidase SppA.
14. A method for constructing the recombinant Bacillus subtilis according to claim 1, characterized in that: The method comprises introducing a gene encoding a recombinant protein and a gene encoding an enhancement factor into Bacillus subtilis; the gene encoding the enhancement factor comprises a gene encoding a class A penicillin binding protein PonA, a class A penicillin binding protein PonA truncated body, an ABC pathway transport protein OppA or a signal peptide peptidase SppA.
15. The method according to claim 14, characterized in that The gene encoding the class A penicillin-binding protein PonA has a nucleotide sequence shown in any one of SEQ ID NO.11 to SEQ ID NO.
15.
16. The method according to claim 14, characterized in that The gene encoding the truncated form of the class A penicillin-binding protein PonA has a nucleotide sequence shown in any one of SEQ ID NO.16 to SEQ ID NO.
20.
17. Use of the recombinant Bacillus subtilis according to any one of claims 1 to 9 in the production of ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
18. The method according to claim 17, characterized in that The application is to culture the recombinant bacteria in a fermentation medium for a period of time and collect the ultrahigh temperature amylase, medium temperature amylase or sucrose isomerase.
19. The method according to claim 17 or 18, characterized in that Feed was also carried out during the fermentation process.
20. Use of the recombinant Bacillus subtilis according to any one of claims 1 to 9 or the method according to any one of claims 10 to 19 in the production of products in the fields of food, chemical industry, sugar production, feed, etc.
Citation Information
Patent Citations
Method for expressing alpha-amylase in bacillus subtilis
CN112553134A
Method for improving expression quantity of recombinant protein in bacillus subtilis by co-expressing bacillus source enhancing factor
CN116656588A
Enhanced Protein Production in Bacillus
US20110117598A1
